EUVIMEDEUVIMED entdecken
KorrekturKohortenstudieOpen Access · CC BY-NC 4.0

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study

BMJ · 28.04.2025 · 389 · r845

DOI: 10.1136/bmj.r845 ↗

Kurz gefasst

Korrektur in der Zeitschrift BMJ, online erschienen am 28.04.2025. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2025). Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. BMJ, 389, r845. https://doi.org/10.1136/bmj.r845

Vancouver

Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. BMJ. 2025;389:r845. doi:10.1136/bmj.r845

BibTeX
@article{euvimed2025,
  title = {Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study},
  journal = {BMJ},
  year = {2025},
  volume = {389},
  pages = {r845},
  doi = {10.1136/bmj.r845}
}
Kostenlos starten →